Showing 2361-2370 of 7028 results for "".
New Products
https://practicaldermatology.com/columns/new-products/new-products-4/23753/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-36/23740/Applying White Glove Service in the Practice
https://practicaldermatology.com/topics/practice-management/applying-white-glove-service-in-the-practice/23643/Help set your practice apart with these tips for providing unparalleled customer service to your patients.Unintended Consequences: Face Masks and Cosmetic Healing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/unintended-consequences-face-masks-and-cosmetic-healing-1/23612/Wearing a face covering to reduce risk of COVID-19 may compromise healing from cosmetic surgery. Should lower face procedures be postponed?DermWireTV: Cosentyx for Kids; Anifrolumab for SLE, Tremfya in PsA at EULAR
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cosentyx-for-kids-anifrolumab-for-sle-tremfya-in-psa-at-eular/19948/FDA has approved Cosentyx (secukinumab) from Novartis for patients as young as six years old. The 2nd Annual San Diego Dermatology Symposium kicks off as a live Virtual Experience next Friday. A post-hoc analysis of pooled data from the TULIP Phase 3 clinical trials shows that anifrolumab improvesPulse’s CellFX for Dermatologic Applications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pulses-cellfx-for-dermatologic-applications/23464/A novel technology targets cells to treat warts, sebaceuous hyperplasia, and more.Reclaiming “Quality” in Dermatology
https://practicaldermatology.com/topics/practice-management/reclaiming-quality-in-dermatology/23432/Dermatologists know quality care when they see it. It’s time to take an active role in defining meaningful quality measures.DermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weighPhysician Spotlight: Adam J. Friedman, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-adam-j-friedman-md/23375/Ask Dr. Friedman
https://practicaldermatology.com/topics/psoriasis/ask-dr-friedman/23360/Answers to Your Questions About Skincare, Disease Management, and More